A Study of Multiple Doses of LY2922470 in Participants With Diabetes

Inclusion Criteria:

- Must be a male, or a female who cannot become pregnant, and who has type 2 diabetes

- Have a glycated hemoglobin (HbA1c) value of greater than or equal to 6.5% and less
than or equal to 11% at screening

- Do not have any change to their diabetes treatment (exercise with or without
metformin) for at least 4 weeks prior to screening

- Have a screening body mass index (BMI) of 18.0 to 45.0 kilograms per square meter
(kg/m^2)

- Have blood pressure, pulse rate, blood and urine laboratory test results acceptable
for the study

Exclusion Criteria:

- Are currently participating in another clinical study or completed one in the last 30
days

- Have a history of significant heart, lung, liver, kidney, stomach or brain disease, or
have any medical problems which may cause an increased risk during the study

- Have electrocardiogram (ECG) readings that are not suitable for the study

- Are infected with hepatitis B or hepatitis C

- Are infected with human immunodeficiency virus (HIV)

- Have donated blood equal to or more than 500 mL within 56 days before the first dose
of drug or have donated plasma within 7 days before the first dose or provided any
blood donation within the last month from screening